Researchers at the University of Arizona R. Ken Coit College of Pharmacy have developed a new strategy that helps the immune system recognize and attack lung cancer tumors more effectively.

Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the odds of a tumor developing. By Nina Agrawal Scientists have made a discovery ...

At least 12 of my colleagues boarded planes to the American Society of Clinical Oncology conference in Chicago last week to hear Charles Swanton of the Francis Crick Institute in London share results ...

For decades, cancer screening has relied on imaging, bloodwork, and invasive testing. Now, one biotech company is taking a different approach. They’re combining dogs, breath samples, and AI to help ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Non-small cell lung cancer is ...

Lung cancer remains the leading cause of cancer-related mortality worldwide despite advances in early detection and treatment. Furthermore, its epidemiology has undergone a profound transformation, ...

PARIS--(BUSINESS WIRE)--Sensome, the pioneer of microsensing technology for real-time, intra-operative tissue analysis, today announced positive results from its first-in-human INSPECT study ...

Abstract: The issue of lung cancer diagnosis at early and correct stage is needed to enhance survival of patients and lower per capita mortality across the globe. Initially screening is commonly ...

A urine test developed by scientists at the University of Cambridge has moved a step closer to clinical use following new findings revealing it could do more than first thought. Originally designed to ...

Please provide your email address to receive an email when new articles are posted on . Less than half of older adults with metastatic lung cancer received systemic treatment. Findings underscore the ...

A new artificial intelligence tool called Sybil is helping doctors predict lung cancer risk years before it appears on scans, potentially closing gaps in current screening guidelines. Standard lung ...